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Chu-Pak Lau, MD, FACC,* Hung-Fat Tse, MB,* Gregory M. Ayers, MD, PHD, FACC†
Hong Kong, China and Redmond, Washington
OBJECTIVES Our aim was to evaluate a potential focal source of atrial fibrillation (AF) by unmasking
spontaneous early reinitiation of AF after transvenous atrial defibrillation (TADF), and to
describe a method of using repeated TADF to map and ablate the focus.
BACKGROUND Atrial fibrillation may develop secondary to a rapidly discharging atrial focus that the atria
cannot follow synchronously, with suppression of the focus once AF establishes. Focus
mapping and radiofrequency (RF) ablation may be curative but is limited if the patient is in
AF or if the focus is quiescent. Early reinitiation of AF has been observed following
defibrillation, which might have a focal mechanism.
METHODS We performed TADF in patients with drug-refractory lone AF using electrodes in the right
atrium (RA) and the coronary sinus. When reproducible early reinitiation of AF within 2 min
after TADF was observed that exhibited a potential focal mechanism, both mapping and RF
ablation were performed to suppress AF reinitiation. Clinical and ambulatory ECG
monitoring was used to assess AF recurrence.
RESULTS A total of 44 lone AF patients (40 men, 4 women; 32 persistent, 12 paroxysmal AF) with a
mean age of 58 6 13 years underwent TADF. Sixteen patients had early reinitiation of AF
after TADF, nine (20%; 5 paroxysmal) exhibited a pattern of focal reinitiation. Earliest atrial
activation was mapped to the right superior (n 5 4) and the left superior (n 5 3) pulmonary
vein, just inside the orifice, in the seven patients who underwent further study. At the onset
of AF reinitiation, the site of earliest activation was 86 6 38 ms ahead of the RA reference
electrogram. The atrial activities from this site were fragmented and exhibited progressive
cycle-length shortening with decremental conduction to the rest of the atrium until AF
reinitiated. Radiofrequency ablation at the earliest activation site resulted in suppression of
AF reinitiation despite pace-inducibility. Improved clinical outcome was observed over 8 6
4 months’ follow-up.
CONCLUSIONS Transvenous atrial defibrillation can help to unmask, map, and ablate a potential atrial focus
in patients with paroxysmal and persistent AF. A consistent atrial focus is the cause of early
reinitiation of AF in 20% of patients with lone AF, and these patients may benefit from this
technique. (J Am Coll Cardiol 1999;33:1217–26) © 1999 by the American College of
Cardiology
The limitations of drug treatment in maintaining sinus
rhythm in patients with atrial fibrillation (AF) include the
relatively low efficacy rate, and the risk of proarrhythmia
with the present medications (1–5). These limitations have
sped the investigation of nonpharmacologic therapies for
AF, such as the use of radiofrequency (RF) catheter ablation
for ventricular rate control (6–11), and more recently, the
use of atrial defibrillators for restoration of sinus rhythm
(12). The former involves either the complete (6–8) abla-
tion of the atrioventricular node with implantation of
permanent pacemaker, or modification of the capacity of the
atrioventricular nodal conduction (9–11). However, after
RF ablation, the atria continue to fibrillate, and patients are
deprived of the hemodynamic benefit of synchronized atrial
contraction, and they continue to be exposed to the risk of
thromboembolism.
It would be preferable to abolish AF by RF ablation of
the atrium itself. Based on Moe’s concept (13) that AF
occurs as a result of multiple atrial wavelets, Cox et al.
(14,15) devised ingenious surgical procedures that divide the
atrium into separate compartments that are electrically
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connected but such that each is too small to sustain an AF
wavelet, the so-called maze operation. This has been shown
to be effective not only in achieving sinus rhythm, but also
in maintaining normal atrial mechanical function in 80% of
cases (15). Attempts have been made to reproduce the maze
procedure by creating linear lines using catheter RF ablation
around anatomical landmarks in either the right atrium
(RA) or the left atrium (LA) or both (16–21). These have
led to variable success rates, as ablation is limited by the
difficulty in achieving a complete line of electrical block.
The procedures tend to be lengthy and are associated with
significant morbidity.
After the creation of RF ablation lines, it was observed
that in some cases of paroxysmal AF, the fibrillatory activity
was converted to an “organized” activity (20). In some patients,
atrial flutter, sustained monomorphic atrial tachycardia or
repetitive extrasystoles that triggered episodes of AF were
noted after linear ablation. These arrhythmias required sepa-
rate ablation. More recently, a rapidly discharging focus has
been reported to occur in patients with paroxysmal AF, which
lead to an electrocardiographic (ECG) pattern of coarse AF
(22). Ablation of these foci was associated with clinical cure of
AF. However, in both cases it is difficult to locate the focus
if the patient is in AF or develops AF during the procedure,
as disorganized electrical activation during AF precludes the
ability to accurately map, study and ablate the arrhythmia.
Furthermore, the extent to which such foci occur in the
overall population of patients with AF is unknown.
In about 30% of patients after external or transvenous
atrial defibrillation (TADF), early reinitiation of AF within
minutes of defibrillation has been observed (23–28). A
consistent atrial ectopic is the cause of reinitiation in some
cases. We hypothesize that a discharging focus is the cause
of AF reinitiation after atrial defibrillation, and RF ablation
to eliminate this focus will prevent AF reinitiation.
Our objectives in this study were 1) to examine the
incidence of a rapidly discharging atrial focus acting as a
precursor arrhythmia that leads to AF in patients without
structural heart disease, and 2) to describe a new method by
which defibrillation, mapping and ablation are used to
identify and abolish this focus in patients who present in
either sinus rhythm or AF.
METHODS
Patients. We performed TADF and electrophysiologic
study in 44 consecutive patients (40 men, 4 women) with
symptomatic, drug-refractory AF who had no significant
underlying structural heart disease. Both TADF and the
electrophysiologic study were performed in these patients
for restoration of sinus rhythm and to evaluate nonpharma-
cologic therapy. There were 32 patients with persistent and
12 patients with paroxysmal AF, respectively, and the mean
age was 58 6 13 years. Patients had symptoms ranging from
continuous (persistent AF patients) to once per week.
Transvenous atrial defibrillation (TADF) was used as the
first procedure in patients with persistent AF and was used
to restore sinus rhythm after AF induction in patients who
were initially in sinus rhythm at the time of study. The
protocol of the study was approved by the ethics committee
of the University of Hong Kong, and all patients gave
written informed consent.
Procedure and catheter placement. The procedure was
performed in the fasting state and consisted of a combina-
tion of TADF, mapping and RF ablation. Multipolar
catheters were introduced from both femoral veins and the
left subclavian vein under local anesthesia. A pair of 7F
custom-made decapolar catheters (Elecath, Rahway, New
Jersey) were advanced to the anterolateral RA and the distal
coronary sinus (CS). Quadripolar catheters were also placed
in the high interatrial septum, the atrioventricular junction
and the right ventricular apex (Fig. 1A). Intravenous (IV)
heparin, 3000 U, was given as a bolus once all catheters were
in place, followed by 1000 U hourly during the remainder of
the procedure. Sedation using IV midazolam and pethidine
was commenced before TADF. Continuous recording of at
least two surface ECG leads and intracardiac recordings
(filtered at 30 to 500 Hz) were performed using a mul-
tichannel recorder (PPG, Midas 5000, Lenexa, Kansas or
Prucka, Cardio Lab EP 4.0, Houston, Texas).
Transvenous atrial defibrillation. The details of TADF in
our center has been reported (29). In brief, defibrillation was
performed along the RA to CS shock vector using 3 3 3 ms
biphasic shocks delivered from an external defibrillator
(XAD, InControl, Redmond, Washington). After a test
shock of 10 V, defibrillation testing was started at 180 V
with the shock strength increased in 40-V steps until
defibrillation was achieved. Conversely, a 40-V stepdown
was used in patients in whom sinus rhythm was restored at
180 V until defibrillation failed. Repeated defibrillation was
subsequently performed at least 40 V above this defibrilla-
tion limit. For patients who were in sinus rhythm, sustained
AF was induced using burst atrial pacing and TADF was
then performed. In one patient who had an implanted atrial
defibrillator (Model 3000, Metrix, InControl, Seattle,
Washington), TADF was performed using the implanted
device.
Abbreviations and Acronyms
AF 5 atrial fibrillation
CS 5 coronary sinus
ECG 5 electrocardiogram, electrocardiographic
IV 5 intravenous
LA 5 left atrium
RA 5 right atrium
RF 5 radiofrequency
TADF 5 transvenous atrial defibrillation
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Mapping of focal AF. Immediately after sinus rhythm was
restored by a TADF shock, a switch box was used to
generate multiple biopolar intracardiac electrograms from
the RA and CS defibrillation catheters. These electrograms
were recorded via the switch box onto the recorder. Con-
tinuous recordings at 100 mm/s were made for up to 2 min
after the shock or until reinitiation of AF occurred. After an
additional 2 min of AF, defibrillation was again carried out
to see whether there was repeatable reinitiation of AF from
a consistent site. In case of absence of recurrence within
Figure 1. Cineangiographic views (A) of catheter layout in a patient undergoing defibrillation-guided mapping and RF ablation of AF
secondary to a focus in the right superior pulmonary vein, just inside the orifice (Patient 2). (B) Recording of spontaneous AF reinitiation
in a patient with a focus just inside the RSPV (same Patient as in A). At the site of putative focus, the atrial electrogram during sinus
rhythm is fragmented. A rapidly discharging focus with fragmented electrograms and a reproducible coupling interval of 200 ms to the
sinus beat initiates a nonsustained, then a sustained run of AF. The first beat of the focus (*) is 115 ms (not labeled) ahead of the high
right atrial electrogram (RA A9–A10) There was shortening of the cycle length after the first beat of the focus before the onset of AF.
Because of the rapidity of the tachycardia, some electrograms appeared to be blocked (second and fourth beat after *). Note a similar
activation sequence of the RA, but earlier activation of HIS and RAW electrograms at the first beat of the tachycardia compared to the
sinus beat, with advancement of all CS electrograms suggestive of a LA focus. ABL 5 ablation catheter (at RSPV); CS 5 coronary sinus
(B9, B10 5 proximal CS; B1, B2 5 distal CS); HIS 5 His bundle; LAO 5 left anterior oblique view; RA 5 right atrium (A9, A10 5
high RA; A1, A2 5 low RA); RAO 5 right anterior oblique view; RAW 5 high right interatrial septum; RV 5 right ventricular apex;
RSPV 5 right superior pulmonary vein. Each calibration mark on the left represents 1 mV for that and the following recordings until a
change in calibration was made.
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2 min, AF reinduction was performed by burst atrial pacing,
and the TADF protocol was repeated for up to a total of
three times. If there was no AF recurrence, mapping of a
potential focus for AF was abandoned.
For patients who developed early reinitiation of AF, the
following observations were noted: 1) electrogram charac-
teristics of the earliest activation site during AF reinitiation;
2) coupling intervals of the first three atrial electrical
activations before degeneration into AF; and 3) pattern of
AF reinitiation, which included the earliest site of activation
that consistently reinitiated AF. If this initial mapping of
the reinitiation of AF was indicative of an atrial focus,
additional right and left atrial mapping was performed to
locate the focus site more precisely. Left atrial mapping and
ablation were performed using standard Brockenbrough
transeptal needle puncture technique and a long sheath
(SL-2, Daig, Minnetonka, Minnesota). Cycle lengths of
potential sites of the focus were measured from the ablation
catheter electrogram using the onset of high-frequency
electrical activity when present or from the initial rapid
departure from baseline when absent.
RF ablation. An 8F 4-mm tip mapping catheter (Marinr,
Medtronic Inc., Minneapolis, Minnesota) was used to
deliver RF energy at the earliest atrial focus that initiated
AF. With a maximum wattage set at 50 W, RF energy was
applied to achieve a temperature of 55° to 60°C for up to
2 min using a RF generator (Atakr, Medtronic Inc.,
Minneapolis, Minnesota). Successful ablation was defined
as disappearance of early reinitiation of AF. A “safety”
application was routinely applied at the successful site. After
ablation, reinduction of AF by burst atrial pacing was
attempted using the ablation catheter at the successful site
and at the high RA. Reinduction of AF and repeated
TADF, with and without isoprenaline, were performed to
assess the suppression of early reinitiation of AF.
Postablation care and follow-up. All catheters were re-
moved after the procedure, and hemostasis was achieved
using direct pressure. Low-molecular-weight heparin in a
dose of 10,000 U/d was given subcutaneously for two weeks
after the procedure for patients with a history of paroxysmal
AF, and was changed soon after the procedure to warfarin
anticoagulation, continued for three months at a therapeutic
international normalized ratio, in patients with persistent
AF. All patients were given an event recorder and under-
went periodic Holter monitoring for documentation of
arrhythmia recurrence. They were seen in the arrhythmia
clinic at 2, 4, and then every 8 weeks for evaluation of AF
recurrence. Routine transthoracic echocardiography was
performed before, immediately after and at three months’
postablation to assess left ventricular function, presence or
absence of pericardial effusion, left atrial clots and pulmo-
nary arterial pressure. Doppler flow measurements of the
pulmonary veins were made at approximately three months’
postprocedure using transthoracic methods. Transesopha-
geal echocardiography was performed on follow-up to assess
potential pulmonary vein stenosis after ablation.
Statistical analysis. Results are expressed as mean 6 SD.
Differences were evaluated by paired or unpaired Student t
test for continuous variables. A value of p , 0.05 was
considered statistically significant.
RESULTS
A total of 44 patients with lone AF underwent TADF. Of
these, 12 patients had paroxysmal AF and the remaining 32
patients had AF for at least 1 month (mean: 27 6 29
months, range: 1.5 to 120 months). Six of 12 patients with
paroxysmal AF had early recurrence of AF during the
TADF procedure, of which five patients (42%) showed a
consistent atrial activation pattern and coupling intervals to
the sinus beat suggestive of a focal initiation. Of 32 patients
with persistent AF, 10 had early reinitiation of AF, of which
4 (13%) showed an atrial activation pattern suggestive of a
consistent focus. These 9 patients were younger than those
without a consistent focus for reinitiation of AF (40 6 10
vs. 62 6 9 years, p , 0.001). The left atrial diameter and
ejection fraction on echocardiography were 37 6 4 mm and
68 6 11%, respectively. Of these nine patients, seven
consented to participate in RF ablation, which was per-
formed as a one-stage procedure in two patients, and on
separate occasions in the remaining patients. These patients
had daily episodes of palpitation despite the use of a class Ic
drug and sotalol.
Earliest site of reinitiation of AF. Four patients were in
AF at the time of the study, and AF was induced in the
remaining patients. In all nine patients, AF was successfully
defibrillated with an atrial defibrillation limit of 240 6 30 V
(approximately 1.6 J). Early reinitiation of AF occurred with
a mean of 23 6 7 s (range 3 to 120 s). In all patients, the RA
(including the right posterior interatrial septum) electro-
grams of the first beat of tachycardia showed a similar
pattern, with subtle differences, as compared with sinus
rhythm (Fig. 1B; Fig. 2). Conversely, the CS electrograms
were significantly advanced as compared with sinus rhythm,
suggestive of a LA focus. Of the seven patients undergoing
RF ablation, four foci were mapped to the right superior
pulmonary vein, just inside the orifice, and the remaining
three foci to the left superior pulmonary vein, just inside the
orifice. The earliest site determined to be the focus was
86 6 38 ms (range 40 to 140 ms) ahead of the high RA
reference electrogram.
Characteristics of the atrial electrogram. During sinus
rhythm, the atrial site of the earliest activation showed a
fragmented electrogram pattern identified by first entering
one of the pulmonary veins and withdrawing the catheter
until a fragmented atrial electrogram was recorded. In five of
seven patients, the electrogram during sinus rhythm showed
an initial low frequency component followed by a high-
frequency component (Fig. 2). At the first tachycardia beat,
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the high-frequency component appeared to advance ahead
of the low-frequency component. In the other two patients,
only a single electrogram signal was observed and it ad-
vanced in time at the onset of the tachycardia with respect
to both the surface P-wave and high RA electrogram. There
was a shortening of the cycle lengths of the second and the
third beat of the focus compared with the first one before
AF initiation (Table 1); the focus thereafter was usually
overdriven by the fibrillation wavelets. Progressive decre-
mental conduction to the remainder of the atrium was
observed prior to AF reinitiation.
RF ablation. Radiofrequency energy (mean number of RF
applications: 13 6 7) was applied at the putative site of the
AF-initiating focus and resulted in suppression of AF
reinitiation in all patients (Fig. 3A and B). In four patients,
modification of the focus occurred, resulting in only single
ectopic beats that did not reinitiate AF. During the “safety”
application of RF energy, these single ectopics were
abolished in all patients. In the patient with an implanted
atrial defibrillator, sustained AF was induced and lasted
for over 1 h during the procedure. The RF ablation at the
focus resulted in termination of the AF, followed by
single ectopics and finally normal sinus rhythm. Burst
pacing both at the successful RF ablation site and at the RA
reinduced AF in all patients despite successful RF ablation
to prevent AF reinitiation. No procedural-related compli-
cations occurred, nor was there elevation of serum creatine
phosphokinase.
Follow-up. One patient (Patient 6) with a history of
persistent AF had recurrence of AF on day 2 after the
procedure. He refused further attempts to restore sinus
rhythm, and he continued to receive atrioventricular nodal
blocking agent. The remaining patients were asymptomatic,
and no symptomatic AF occurred in the postprocedural
period via review of Holter or event recordings. No signif-
icant change occurred in left ventricular function nor LA
size during follow-up, nor was there elevation of pulmonary
arterial pressure as measured by echocardiography. There
were no evidence of pulmonary vein stenosis on transesoph-
ageal echocardiography.
Figure 2. Activation of a focus leading to AF in patient 7 from just inside the left superior pulmonary vein (LSPV, HIS potential was of
low amplitude). The first beat of the focus (*) was 58 ms (not labeled) ahead of the high RA electrogram. In this patient, decremental
conduction occurred from the focus to the rest of the atrium, and advancement of CS electrograms compared to the sinus beat. At the
ablation catheter, the atrial electrogram shows an initial rounded then a fast component during sinus rhythm, which appears to reverse and
separate at the first beat of tachycardia. Abbreviations as in Figure 1. Each calibration mark on the left represents 1 mV for that and the
following recordings until a change in calibration was made.
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DISCUSSION
Precursor arrhythmias for AF. Early reinitiation of AF
has been described (23–27), and it seems to occur in up to
30% of patients after either external (23,24) or transvenous
atrial defibrillation (25–27). The mechanisms of AF reini-
tiation are probably multiple, but a consistent atrial ectopic
activation sequence was observed in some patients. These
ectopic beats usually exhibit a higher prematurity index than
those that do not initiate AF (26,27). Early reinitiation of
AF is also associated with a higher incidence of late AF
recurrence despite early suppression with class Ic antiar-
rhythmic agents (24), but may be reduced with intracellular
calcium-lowering medications (28).
In this study we observed that a consistent atrial focus was
responsible for early reinitiation of AF in 20% of patients
with lone AF who underwent elective transvenous defibril-
lation. These atrial foci typically occurred around the
pulmonary vein or the crista terminalis as described by Jais
et al. (22). Apart from a consistent coupling cycle length of
the first ectopic beat, we observed that these left atrial foci
are recognized by a distinct pattern of atrial activation with
advancement of the CS atrial electrograms relative to the
RA electrograms when compared to the activation during
sinus rhythm. This pattern of initiation was helpful as an
indicator for left-sided mapping.
We further observed that the electrograms in the area of
the focus typically showed a fragmented pattern of electrical
activity with shortening of its cycle length and decremental
conduction to the rest of the atria before AF was initiated.
As described in preliminary communications (20,30), the
electrogram at the pulmonary venous orifices is multicom-
ponent, with an initial lower frequency far-field atrial
component and a high-frequency component during sinus
rhythm, with advancement of the high-frequency spike
compared with the lower frequency electrogram at the onset
of tachycardia. In our study we observed a similar complex
electrogram in five of seven patients. An anatomical basis
for such atrial foci to occur in the pulmonary vein had been
suggested by Nathan and Eliakim (31), who demonstrated
the presence of atrial myocardial sleeves extending 1 to 2 cm
into the pulmonary veins.
Precursor rhythms for AF have been previously described,
where the degeneration of the precursor rhythm leads to AF
(32–37). These precursor rhythms include the atrioventric-
ular reentrant arrhythmias of the Wolff-Parkinson-White
syndrome (32,33), atrial flutter (34), and, more recently,
atrioventricular nodal reentrant tachycardia (35). Elimina-
tion of these precursor arrhythmias may lead to either a cure
or amelioration of AF (34,36,37). We found that an atrial
tachyarrhythmia emanating from an isolated focus was a
precursor arrhythmia for AF in our patients with reproduc-
ible, spontaneous reinitiation of AF following TADF.
Furthermore, during the brief runs of atrial activations from
the focus, decremental conduction occurred to the rest of
the atrium owing to the short cycle length of the tachycar-Ta
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Figure 3. Suppression of early reinitiation of AF after RF ablation of a focus in the right superior pulmonary venous orifice (patient 5).
(A) Before ablation, AF recurred consistently within 10 s after a 1.2-J transvenous atrial defibrillation shock. (B) After ablation, sinus
rhythm remained after restoration of induced AF. Recording artifact occurred during switching from the defibrillation to the recording
mode. Abbreviations as in Figure 1.
dia, which may lead to reentry and establishment of AF
wavelets. Finally, we noted that the organized electrical
activity emanating from the focus was suppressed once AF
was reestablished, thereby requiring repeated TADF to map
the focus accurately. Suppression of early reinitiation of AF
by RF ablation led to an improved clinical outcome. Thus,
by unmasking a focus that initiates AF with repeated
TADF, our technique allows mapping and ablation of this
focus in patients who are either in sinus rhythm or in AF.
Interestingly, despite eventual arrhythmia control during
the follow-up period, AF remained inducible by burst atrial
pacing at the successful RF site and at the high lateral RA
immediately after the ablation in all patients. We postulate
that atrial remodeling had occurred in these patients as a
result of the rapidly discharging focus in a manner similar to
an atrial fibrillation pacemaker in goats (38). This continued
overdrive of the atria leads to a shortening of atrial refrac-
toriness and loss of its rate adaptation. Reverse remodeling
may take some time to occur, and the atrium may remain
susceptible to AF reinduction even after successful elimina-
tion of the focus (38). Furthermore, elimination of the
triggering precursor arrhythmia does not preclude the pos-
sibility of recurrent AF due to other mechanisms (39).
Defibrillation-guided mapping of focus-initiated AF.
We describe a technique in which TADF was used to
identify a potentially curable cause of AF. By repeated
TADF and observing early reinitiation of AF, mapping of
the putative focus can be achieved and RF catheter ablation
of the focus accomplished. Furthermore, suppression of
early reinitiation of AF can be used as an end point of RF
ablation, as acute AF inducibility may not preclude long-
term improvement in clinical outcome. Repeated TADF
using the described method has been shown to be safe and
without significant proarrhythmia complications and to be
well tolerated by patients (29,40 – 43), provided that
R-wave-synchronized shocks are delivered with a preceding
cycle length that is longer than 500 ms, without a long-short
sequence. We have not observed any proarrhythmia nor
mechanical complications following repeated TADF in any
patients.
Our technique may be an alternative approach to those
reported by Swartz et al. (17) and Haissaguerre et al. (20).
Namely, our technique uses induction of AF and subsequent
TADF for focus manifestation. The other techniques use a
number of stepwise linear ablations and compartmentaliza-
tion of the atrium to smaller electrical masses in an attempt
to prevent AF. Recently, it was reported that in some
patients with paroxysmal AF, after a number of linear
ablations, AF was converted to an organized rhythm (20),
and sustained monomorphic atrial tachycardias or repetitive
extrasystoles triggering episodes of AF were observed.
These tachycardias required separate ablations. It is likely
that these AF-initiating foci were similar to those we
observed after TADF. The method we described would
allow one to elucidate an underlying focal origin of AF
without first going through linear ablation procedure with
its associated morbidity. Furthermore, by limiting ablation
to the focus rather than around the atria, or to several
pulmonary veins, may account for why we have not observed
major morbidity such as pulmonary hypertension in our
patients after ablation. Although our method cannot be
performed in patients who did not have a reproducible
recurrence of AF after TADF, it may be useful as a first
procedure in approximately 20% of patients with lone AF
before contemplating catheter maze procedure.
Our technique may complement the technique of focal
ablation described by Jais et al. (22). These investigators
mapped a putative focus of AF by relying on either
self-terminating runs of an atrial tachycardia that simulate
an ECG appearance of AF, or by ablating frequently
occurring atrial ectopics that were considered to initiate AF.
However, their technique would not be useful for patients
who had persistent AF or in patients who develop sustained
AF during the procedure in that as we have reported, the
focus appears to be passively activated by fibrillatory con-
duction under these conditions. In addition, inducibility of
AF by atrial pacing was suppressed in their study after
successful ablation of the focus. This finding is at odds with
our observation of postprocedure inducibility of AF, which
may be due to the presence of sustained AF in our
population (with three of seven patients in persistent AF at
the time of the study) such that more extensive atrial
remodeling had taken place that favored AF maintenance
after induction by any means. However, we required a larger
number of ablations to achieve suppression of the focus that
was responsible for early AF reinitiation. This may be due to
a difference in end points used or the different population
studied. As the atrial tissue extending inside the pulmonary
vein orifices is significantly larger than the ablation catheter,
accurate mapping and placement of the catheters at the
exact site of the focus was difficult. Alternatively, the focal
source may be larger than can be encompassed by a 4-mm
electrode tip. The use of larger-tip catheters or alternative
catheter designs may reduce the number of RF applications
required.
Study limitations. Although all patients had an acute
procedural success, one patient with persistent AF had AF
recurrence soon after successful ablation. As the patient
refused any further attempts in restoring sinus rhythm, we
cannot comment on whether the recurrence was due to an
inadequately ablated focus or the residual propensity of
developing AF by the remodeled atria. Additionally, a rate
of 33% has been reported for AF recurrence after ablation of
paroxysmal supraventricular tachycardia as a precursor
rhythm for AF (36). Further study is needed to determine
whether failed primary therapy with ablation or a secondary
mechanism (i.e., atrial stretch or alterations in autonomic
tone) is the cause of these AF recurrences.
Finally, of keen interest to the medical community is the
concept of reverse remodeling. As our study consisted of
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only clinical follow-up and additional electrophysiologic
evaluation was beyond the scope of this study, we cannot
address the electrophysiologic changes that may have oc-
curred in our patients as a result of their sustained sinus
rhythm postprocedure. Additionally, there exists no clini-
cally validated methods to evaluate true inducibility of AF as
one must consider factors such as site specificity of pacing to
test this factor. For us to repeat our tests of inducibility after
follow-up, we would need to perform an additional trans-
septal puncture with little benefit to the patient, and for
these reasons we chose not to reassess inducibility as a
measure of atrial reverse remodeling.
Conclusions. Consistent reinitiation of AF after TADF
identifies a subset of patients with AF secondary to an atrial
focus. A technique using atrial defibrillation-guided map-
ping followed by catheter ablation of the focus may lead to
arrhythmia cure in a significant proportion of patients with
lone AF.
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